Raymond James Financial reissued an “outperform” rating on shares of AbbVie in a research note on Monday, August 25th. Following the completion of the sale, the executive vice president owned 58,247 shares in the company, valued at $11,562,611.97. Following the sale, the executive vice president owned 177,292 shares of the company’s stock, valued at approximately $35,178,278.64. TD Capital Management LLC now owns 128 shares of the company’s stock valued at $27,000 after acquiring an additional 58 shares during the period. Finally, Abound Financial LLC acquired a new position in AbbVie in the first quarter valued at about $30,000.